Bondwell Technologies

Bondwell Technologies is a Texas-based biotechnology company commercializing a revolutionary biomaterial-based platform technology. Founded in 2017 by Texas A&M University scientists, the company leverages the self-assembling properties of the Drosophila transcription factor protein Ultrabithorax (Ubx) to develop high-performance materials. Bondwell's primary product, Bondwell BioPure, is a novel affinity purification platform designed to optimize the purification step in biologic drug manufacturing, particularly for antibody-based therapies. By integrating purification functions directly into a protein-based matrix, Bondwell's single-use, high-capacity membranes reduce complexity and cost while improving flow and performance. The company also collaborates on advanced applications of its platform in tissue engineering, biosensing, and space health.